Fisher & Paykel Healthcare Corporation Limited FPH.AX

Healthcare · Medical Instruments & Supplies · valued as of 2026-11-03 · statements 2026-03-31

Average Intrinsic Value
$2.82B
Market Cap
$15.22B
Margin of Safety
-439.6%
Intrinsic / Market Ratio
0.19

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

4.50B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

2.76B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.21B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

2.82B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

2.82B USD

from the sum above

Market Cap

15.22B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.19×

the ratio the screener ranks by; Margin of Safety -439.6% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 4.50B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)837.74M USD
+②Net Cash Today180.28M USD
+③Growth Value3.48B USD
=Value4.50B USD

EPV of the Operations (NOPAT over WACC)

837.74M USD

Net cash today

+180.28M USD

Growth Value

+3.48B USD

Value

4.50B USD

①EPV (earnings power value)

837.74M USD

②Net Cash Today

180.28M USD

③Growth Value

3.48B USD

Market value

Market Cap15.22B USD

Today's price times the shares.

Value vs market

Margin of Safety-238.5%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 2.76B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE2.06B USD
+②Equity at Year 15, Today698.71M USD
=Value2.76B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

2.06B USD

②Equity at Year 15, Today

698.71M USD

Market value

Market Cap15.22B USD

Today's price times the shares.

Value vs market

Margin of Safety-452.3%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.21B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an operating profit at or below zero in the latest three years), so the value is the book value today, 1.21B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap15.22B USD

Today's price times the shares.

Value vs market

Margin of Safety-1157.3%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 9.87%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.90×Market Risk Premium 6.00%= 9.89%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 93.29M USDPretax Income 361.41M USD= 25.81%

The tax the interest saves.

Interest Expense =EBIT 367.31M USD−Pretax Income 361.41M USD= 5.89M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 5.89M USDTotal Debt 83.61M USD×(1 − Tax Rate for WACC 25.81%)= 5.23%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 83.61M USDMarket Cap + Total Debt 15.22B USD + 83.61M USD= 0.55%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.45%×Cost of Equity 9.89%+Debt Weight 0.55%×Cost of Debt 5.23%= 9.87%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 1.63B USD − Total Liabilities 422.48M USD = Book Value Today 1.21B USD

Total Debt 83.61M USD − Cash and Short-Term Investments 263.89M USD = Net Debt Today -180.28M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.6%at most 5%passes587,276,425 / 583,963,682
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets—at least -10.0%not measured(— − 268.13M USD) ÷ 1.63B USD
Price to bookMarket Cap ÷ Book Value Today12.57×at most 3×does not pass15.22B USD ÷ 1.21B USD
Operating marginOperating Income ÷ Revenue20.7%above 10.0%passes273.45M USD ÷ 1.32B USD
Revenue growthRevenue ÷ Revenue a Year Before − 180.6%above 10.0%passes1.32B USD / 731.41M USD
Net cash(Cash − Total Debt) ÷ Market Cap1.2%above -30%passes(263.89M USD − 83.61M USD) ÷ 15.22B USD
Operating efficiencyOperating Income ÷ Gross Profit32.5%above 25.0%passes273.45M USD ÷ 841.35M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

37 USD

Enterprise value

21.30B USD

market cap plus net debt

EV / EBITDA

28.02×

Price / book

12.61×

the provider's book

Price / earnings

57.48×

Return on equity

23.4%

the provider's, not the engine's

Profit margin

20.3%

Revenue growth

14.0%

Analyst target, mean

37 USD

Analysts

8

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2023202420252026
Income statement

Revenue

997.01M1.05B731.41M1.32B

Gross profit

593.65M633.77M302.89M841.35M

Operating income

151.06M152.15M-211.95M273.45M

EBITDA

operating income before depreciation and amortisation

272.19M220.21M373.79M458.08M

Pretax income

205.85M140.96M287.53M361.41M

Net income

157.09M79.30M215.49M268.13M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

157.09M79.30M215.49M268.13M

R&D

109.39M118.54M129.62M134.78M
Balance sheet, year end

Total assets

1.38B1.36B1.46B1.63B

Total liabilities

283.11M312.55M377.27M422.48M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.10B1.05B1.08B1.21B

Total debt

91.50M113.09M87.58M83.61M

Cash and equivalents

75.94M49.04M151.10M263.89M

Net PP&E

fixed assets after depreciation

720.62M801.41M764.66M805.36M

Working capital

current assets less current liabilities

304.01M191.32M248.51M374.52M
Cash flow

Operating cash flow

————

Capital expenditure

paid out, so below zero

-132.61M-202.74M-58.84M-111.72M

Depreciation and amortisation

62.13M68.36M79.92M90.77M

Free cash flow

operating cash flow plus capital expenditure

16.88M54.18M254.56M267.84M